These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33115848)

  • 1. Potential Contributions of Anaerobes in Cystic Fibrosis Airways.
    Thornton CS; Surette MG
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33115848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.
    Flynn JM; Cameron LC; Wiggen TD; Dunitz JM; Harcombe WR; Hunter RC
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The airway microbiome in cystic fibrosis and implications for treatment.
    Zemanick ET; Sagel SD; Harris JK
    Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Oct; 11(8):1298-306. PubMed ID: 25167882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.
    Tunney MM; Field TR; Moriarty TF; Patrick S; Doering G; Muhlebach MS; Wolfgang MC; Boucher R; Gilpin DF; McDowell A; Elborn JS
    Am J Respir Crit Care Med; 2008 May; 177(9):995-1001. PubMed ID: 18263800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?
    Su S; Hassett DJ
    Expert Opin Ther Targets; 2012 Sep; 16(9):859-73. PubMed ID: 22793158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Omics Study of Keystone Species in a Cystic Fibrosis Microbiome.
    Silveira CB; Cobián-Güemes AG; Uranga C; Baker JL; Edlund A; Rohwer F; Conrad D
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of anaerobic bacteria in the cystic fibrosis airway.
    Sherrard LJ; Bell SC; Tunney MM
    Curr Opin Pulm Med; 2016 Nov; 22(6):637-43. PubMed ID: 27455453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract.
    Kiedrowski MR; Bomberger JM
    Front Immunol; 2018; 9():3067. PubMed ID: 30619379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis: a polymicrobial infectious disease.
    Sibley CD; Rabin H; Surette MG
    Future Microbiol; 2006 Jun; 1(1):53-61. PubMed ID: 17661685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria.
    Castner LM; Zimbric M; Cahalan S; Powell C; Caverly LJ
    J Cyst Fibros; 2021 Nov; 20(6):926-931. PubMed ID: 33612403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genus Prevotella in cystic fibrosis airways.
    Field TR; Sibley CD; Parkins MD; Rabin HR; Surette MG
    Anaerobe; 2010 Aug; 16(4):337-44. PubMed ID: 20412865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaerobes in cystic fibrosis patients' airways.
    Lamoureux C; Guilloux CA; Beauruelle C; Jolivet-Gougeon A; Héry-Arnaud G
    Crit Rev Microbiol; 2019 Feb; 45(1):103-117. PubMed ID: 30663924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.